NYSE:GMRE - Global Medical REIT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $17.00
  • Forecasted Upside: 31.99 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$12.88
▲ +0.08 (0.63%)

This chart shows the closing price for GMRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Global Medical REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GMRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GMRE

Analyst Price Target is $17.00
▲ +31.99% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Global Medical REIT in the last 3 months. The average price target is $17.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 31.99% upside from the last price of $12.88.

This chart shows the closing price for GMRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Global Medical REIT. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/10/2022B. RileyLower Price Target$18.00 ➝ $16.00High
3/2/2022B. RileyLower Price Target$20.00 ➝ $18.00High
9/20/2021KeyCorpInitiated CoverageOverweight$17.00Low
7/9/2021Colliers SecuritiesInitiated CoverageBuy$18.00Medium
6/15/2021B. RileyBoost Price TargetBuy$16.00 ➝ $18.00Low
4/16/2021BMO Capital MarketsInitiated CoverageOutperform$16.00Medium
9/1/2020Stifel NicolausReiterated RatingBuy$15.00High
7/1/2020Berenberg BankInitiated CoverageBuy$13.00Medium
3/18/2020B. RileyUpgradeNeutral ➝ Buy$16.00 ➝ $12.00High
3/6/2020Robert W. BairdBoost Price TargetOutperform$14.00 ➝ $17.00Medium
3/6/2020B. RileyDowngradeBuy ➝ Neutral$15.00 ➝ $16.00High
3/5/2020Stifel NicolausBoost Price TargetBuy$14.00 ➝ $16.00High
2/7/2020National SecuritiesInitiated CoverageBuy$16.00Low
1/7/2020Janney Montgomery ScottUpgradeNeutral ➝ Buy$14.50Medium
12/20/2019B. RileyBoost Price TargetBuy$13.00 ➝ $15.00Medium
12/17/2019Stifel NicolausBoost Price TargetBuy$12.00 ➝ $14.00Low
5/10/2019Boenning ScattergoodReiterated RatingBuy$11.00High
4/15/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$11.00Medium
3/8/2019B. RileySet Price TargetBuy$11.00High
3/7/2019Boenning ScattergoodReiterated RatingBuyMedium
12/19/2018Janney Montgomery ScottDowngradeBuy ➝ Neutral$9.03High
11/12/2018B. RileyReiterated RatingBuyLow
11/7/2018Boenning ScattergoodUpgradeNeutral ➝ Buy$11.00Low
10/11/2018Robert W. BairdInitiated CoverageOutperform$11.00Medium
8/10/2018B. RileySet Price TargetBuy$11.00Medium
8/9/2018Boenning ScattergoodReiterated RatingHoldMedium
6/29/2018Boenning ScattergoodReiterated RatingNeutralLow
5/10/2018B. RileyLower Price TargetBuy ➝ Buy$10.50 ➝ $10.00High
3/28/2018DA DavidsonUpgradeNeutral ➝ Buy$8.00High
3/8/2018B. RileyReiterated RatingBuyLow
3/7/2018Cantor FitzgeraldInitiated CoverageBuy$12.00High
11/10/2017B. RileyReiterated RatingBuy$10.50N/A
11/1/2017B. RileyReiterated RatingBuyN/A
9/18/2017FBR & Co.Reiterated RatingBuy$10.00 ➝ $10.50High
9/1/2017Cantor FitzgeraldReiterated RatingOverweight$12.00Medium
8/22/2017DA DavidsonDowngradeBuy ➝ Neutral$11.00 ➝ $10.00High
7/11/2017FBR & Co.Reiterated RatingOutperform$10.00Low
(Data available from 5/26/2017 forward)

News Sentiment Rating

0.08 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2022
  • 4 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/25/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
5/26/2022

Current Sentiment

  • 2 very positive mentions
  • 8 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Global Medical REIT logo
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Read More

Today's Range

Now: $12.88
Low: $12.80
High: $12.94

50 Day Range

MA: $14.86
Low: $12.49
High: $16.42

52 Week Range

Now: $12.88
Low: $12.20
High: $18.51

Volume

4,884 shs

Average Volume

419,104 shs

Market Capitalization

$843.87 million

P/E Ratio

64.00

Dividend Yield

6.68%

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Global Medical REIT?

The following equities research analysts have issued stock ratings on Global Medical REIT in the last year: B. Riley, Colliers Securities, KeyCorp, StockNews.com, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for GMRE.

What is the current price target for Global Medical REIT?

0 Wall Street analysts have set twelve-month price targets for Global Medical REIT in the last year. Their average twelve-month price target is $17.00, suggesting a possible upside of 31.9%.
View the latest price targets for GMRE.

What is the current consensus analyst rating for Global Medical REIT?

Global Medical REIT currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GMRE will outperform the market and that investors should add to their positions of Global Medical REIT.
View the latest ratings for GMRE.

How do I contact Global Medical REIT's investor relations team?

Global Medical REIT's physical mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company's listed phone number is (202) 524-6851 and its investor relations email address is [email protected] The official website for Global Medical REIT is www.globalmedicalreit.com. Learn More about contacing Global Medical REIT investor relations.